Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Post by carduon Jul 12, 2011 12:43pm
408 Views
Post# 18822764

We didn'y make the list!

We didn'y make the list!Below is a message from another board. I wonder why we're not on this list?

"Here are the rest of the top 15 most-watched companies in the industry with their watch interest along with the stocks' CAPS rating to show the sentiment of our investing community."

Company
Market Cap (in millions)
CAPS Rating (out of 5)
Watch Interest
1
Gilead Sciences
$33,403
****
6.3%
2
Dendreon (Nasdaq: DNDN)
$5,931
**
6.2%
3
PDL BioPharma
$803
****
5.6%
4
Cell Therapeutics (Nasdaq: CTIC)
$259
**
5.1%
5
Amgen
$53,590
****
4.7%
6
Aeterna Zentaris (Nasdaq: AEZS)
$220
****
3.8%
7
XOMA
$70
**
3.3%
8
Geron (Nasdaq: GERN)
$566
***
3.1%
9
Orexigen Therapeutics
$80
**
2.9%
10
Zalicus (Nasdaq: ZLCS)
$273
***
2.6%
11
Spectrum Pharmaceuticals
$530
****
2.5%
12
Ariad Pharmaceuticals
$1,605
**
2.5%
13
StemCells
$84
**
2.1%
14
Momenta Pharmaceuticals (Nasdaq:MNTA)
$1,052
****
2.1%
15
Biogen Idec
$25,949
***
2.0%
Sources: Motley Fool, Motley Fool CAPS.
Bullboard Posts